Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5074
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFonseka, Sanjeewani-
dc.contributor.authorWijeyaratne, Chandrika N-
dc.contributor.authorGawarammana, Indika B-
dc.contributor.authorKalupahana, Nishan-
dc.contributor.authorRosairo, Shanthini-
dc.contributor.authorRatnatunga, Neelakanthi-
dc.contributor.authorKumarasiri, Ranjith-
dc.date.accessioned2021-02-22T17:41:01Z-
dc.date.available2021-02-22T17:41:01Z-
dc.date.issued2020-
dc.identifier.citationFonseka S, Wijeyaratne CN, Gawarammana IB, Kalupahana NS, Rosairo S, Ratnatunga N, Kumarasiri R. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study. J Clin Aesthet Dermatol. 2020 Jul;13(7):18-23. Epub 2020 Jul 1.en_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/5074-
dc.description.abstractBACKGROUND: The effectiveness of different combined oral contraceptive pills and metformin in reducing hirsutism in patients with polycystic ovary syndrome (PCOS) remains unclear. OBJECTIVE: We sought to determine the effects of ethinylestradiol (35μg)/cyproterone acetate (2mg) (EE/CPA) and ethinylestradiol (20μg)/desogestrel (0.15mg) (EE/DES), alone or with metformin, on hirsutism in PCOS. METHODS: A randomized, double-blind, triple-dummy study was conducted on women with PCOS and hirsutism (N=107) who received one of four drug combinations (Arm A: EE/CPA; Arm B: EE/DES; Arm C: EE/CPA plus metformin; or Arm D: EE/DES plus metformin). Hirsutism was assessed at baseline, six months, and 12 months by using five outcomes variables. RESULTS: No outcomes variable showed a significant difference between the four arms at 12 months. There was a significant reduction in both hair density and modified Ferriman-Gallwey score (mFGS) in Arm A, mFGS in Arm B, hair density in Arm C, and diameter of sideburn hair in Arm D, respectively. Separately, there was a significant increase noted in the hair growth rate of chin and an improvement in patients' perceptions of hirsutism in all four study arms. CONCLUSION: EE/CPA and EE/DES were equally effective in improving hirsutism in PCOS, with no added benefit from low-dose metformin. Sri Lanka Clinical Trials Registry (http://www.slctr.lk) registration no. SLCTR/2015/007. Keywords: Ferriman-Gallwey score; Hirsutism; cyproterone acetate; desogestrel; hair density; hair diameter; hair growth rate; metformin; polycystic ovary syndrome.en_US
dc.language.isoenen_US
dc.publisherEdgemont, PA : Matrix Medical Communicationsen_US
dc.subjectFerriman-Gallwey scoreen_US
dc.subjectHirsutismen_US
dc.subjectcyproterone acetateen_US
dc.subjectdesogestrelen_US
dc.subjecthair densityen_US
dc.subjecthair diameteren_US
dc.subjecthair growth rateen_US
dc.subjectmetforminen_US
dc.subjectpolycystic ovary syndromeen_US
dc.titleEffectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndromeen_US
dc.title.alternativeA Randomized, Double-blind, Triple-dummy Study.en_US
dc.typeArticleen_US
Appears in Collections:Department of Obstetrics & Gynaecology

Files in This Item:
File Description SizeFormat 
jcad_13_7_18.pdf328.3 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.